FDA Approves Two Vonoprazan Therapies for H pylori Eradication FDA Approves Two Vonoprazan Therapies for H pylori Eradication

Vonoprazan-based dual and triple regimens showed superior eradication rates compared with PPI-based triple therapy in a pivotal trial.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news